SGP was established in 2015, registered capital is 17 million U.S. Dollar (RMB120M), consists of scientists, original team and venture-investment, focuses on Liposomal IND for medicine and oral Liposomal for nutraceuticals, total employee around 100 people.

Shanghai Ginposome PharmaTech Co., Ltd. (SGP-Shanghai), it is the R&D center, located at No. 201 Minyi Road, Songjiang District, Shanghai. it covers 1500m2, around 15 Ph.D. and others employees, owns a complete R&D laboratories and QA system, owns more than 60 chemical hoods, 10 sets HPLC, GC, DAC-10, DAC-100, lyophilizer, high pressure homogenizer, microfluidizer, high speed shearing machine, particle size analyzer, etc.